Your browser doesn't support javascript.
loading
ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer.
Leyland-Jones, Brian; Gray, Kathryn P; Abramovitz, Mark; Bouzyk, Mark; Young, Brandon; Long, Bradley; Kammler, Roswitha; Dell'Orto, Patrizia; Biasi, Maria Olivia; Thürlimann, Beat; Harvey, Vernon; Neven, Patrick; Arnould, Laurent; Maibach, Rudolf; Price, Karen N; Coates, Alan S; Goldhirsch, Aron; Gelber, Richard D; Pagani, Olivia; Viale, Giuseppe; Rae, James M; Regan, Meredith M.
Afiliación
  • Leyland-Jones B; Avera Cancer Institute, 1000 E 23rd Street, Sioux Falls, SD, 57105, USA. bleylandj@aol.com.
  • Gray KP; Department of Biostatistics and Computational Biology, International Breast Cancer Study Group Statistical Center, Dana-Farber Cancer Institute, Harvard T. H. Chan School of Public Health, 450 Brookline Ave, Boston, MA, 02215, USA. pkruan@jimmy.harvard.edu.
  • Abramovitz M; VM Institute of Research, 6100 Av Royalmount, Montréal, QC, H4P 2R2, Canada. mark.abramovitz@gmail.com.
  • Bouzyk M; AKESOgen, Inc., 3155 Northwoods Pl NW, Norcross, GA, 30071, USA. mbouzyk@akesogen.com.
  • Young B; Avera Cancer Institute, 1000 E 23rd Street, Sioux Falls, SD, 57105, USA. brandon.young@avera.org.
  • Long B; Genomic and Molecular Pathology, University of Chicago, 900 E 57th St. Room 1260D, Chicago, IL, 60637, USA. bradley.long@uchospitals.edu.
  • Kammler R; International Breast Cancer Study Group Coordinating Center and Central Pathology Office, Effingerstrasse 40, 3008, Bern, Switzerland. rosita.kammler@ibcsg.org.
  • Dell'Orto P; Division of Pathology and Laboratory Medicine, International Breast Cancer Study Group Central Pathology Office, European Institute of Oncology, Via Ripamonti 435, 20146, Milan, Italy. patrizia.dellorto@ieo.it.
  • Biasi MO; Division of Pathology and Laboratory Medicine, European Institute of Oncology, Via Ripamonti 435, 20146, Milan, Italy. olivia.biasi@ieo.it.
  • Thürlimann B; Breast Center, Kantonsspital St. Gallen, Rorschacher Strasse 95, 9007, St. Gallen, Switzerland.
  • Harvey V; Swiss Group for Clinical Cancer Research (SAKK), Bern, Switzerland.
  • Neven P; International Breast Cancer Study Group, Bern, Switzerland.
  • Arnould L; International Breast Cancer Study Group, Bern, Switzerland. vernonh@adhb.govt.nz.
  • Maibach R; Auckland City Hospital, PO Box 26498, Epsom, Auckland, 1344, New Zealand. vernonh@adhb.govt.nz.
  • Price KN; Australia and New Zealand Breast Cancer Trials Group, Newcastle, Australia. vernonh@adhb.govt.nz.
  • Coates AS; Department of Oncology, Multidisciplinary Breast Center, KULeuven (University of Leuven), University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium. patrick.neven@uzleuven.be.
  • Goldhirsch A; Institute Georges François Leclerc, 1 Rue Professeur Marion, BP 77 980, 21079, Dijon Cedex, France. larnould@dijon.fnclcc.fr.
  • Gelber RD; International Breast Cancer Study Group Coordinating Center, Effingerstrasse 40, 3008, Bern, Switzerland. rudolf.maibach@ibcsg.org.
  • Pagani O; International Breast Cancer Study Group Statistical Center, Frontier Science and Technology Research Foundation, 450 Brookline Ave, Boston, MA, 02215, USA. price@jimmy.harvard.edu.
  • Viale G; International Breast Cancer Study Group, Bern, Switzerland. alan.coates@ibcsg.org.
  • Rae JM; University of Sydney, Sydney, Australia. alan.coates@ibcsg.org.
  • Regan MM; International Breast Cancer Study Group, Bern, Switzerland. aron.goldhirsch@ibcsg.org.
Breast Cancer Res Treat ; 154(3): 543-55, 2015 Dec.
Article en En | MEDLINE | ID: mdl-26590813

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tamoxifeno / Triazoles / Neoplasias de la Mama / Receptor alfa de Estrógeno / Receptor beta de Estrógeno / Antineoplásicos / Nitrilos Tipo de estudio: Clinical_trials / Diagnostic_studies / Screening_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Tamoxifeno / Triazoles / Neoplasias de la Mama / Receptor alfa de Estrógeno / Receptor beta de Estrógeno / Antineoplásicos / Nitrilos Tipo de estudio: Clinical_trials / Diagnostic_studies / Screening_studies Límite: Female / Humans / Middle aged Idioma: En Revista: Breast Cancer Res Treat Año: 2015 Tipo del documento: Article País de afiliación: Estados Unidos